תוצאות חיפוש - Matyàs Keltai

Refine Results
  1. 1
    Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion.

    Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. מאת Hanoch Hod, Allan S. Lew, Matyàs Keltai, Bojan Cercek, Ivor Geft, Parth Shah, William Ganz

    יצא לאור 1987
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  2. 2
    Renal function and outcomes in acute coronary syndrome: impact of clopidogrel

    Renal function and outcomes in acute coronary syndrome: impact of clopidogrel מאת Matyàs Keltai, Marcello Tonelli, Johannes F.E. Mann, E Sitkei, Basil S. Lewis, Steven Hawken, Shamir R. Mehta, Salim Yusuf

    יצא לאור 2007
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    Dietary Patterns and the Risk of Acute Myocardial Infarction in 52 Countries

    Dietary Patterns and the Risk of Acute Myocardial Infarction in 52 Countries מאת Romaina Iqbal, Sonia S. Anand, Stephanie Ôunpuu, Shofiqul Islam, Xiaohe Zhang, Sumathy Rangarajan, Jephat Chifamba, Ali T. Al‐Hinai, Matyàs Keltai, Salim Yusuf

    יצא לאור 2008
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  4. 4
    Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease

    Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease מאת Sonia S. Anand, Salim Yusuf, Changchun Xie, Janice Pogue, John W. Eikelboom, Andrzej Budaj, Bruce Sussex, Lisheng Liu, Randolph Guzman, Claudio S. Cinà, Richard Crowell, Matyàs Keltai, Gilbert Gosselin

    יצא לאור 2007
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time

    Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time מאת Ziad Hijazi, Stefan H. Hohnloser, Ulrika Andersson, John H. Alexander, Michael Hanna, Matyàs Keltai, Alexander Parkhomenko, José López‐Sendón, Renato D. Lópes, Agneta Siegbahn, Christopher B. Granger, Lars Wallentin

    יצא לאור 2016
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the <scp>TIMI</scp>‐38 Coronary Stent Registry

    Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the <scp>TIMI</scp>‐38 Coronary... מאת Marc P. Bonaca, Sabina A. Murphy, Debra L. Miller, Jean‐Paul R. Herrman, Shmuel Gottlieb, Matyàs Keltai, Alberto Menozzi, José Carlos Nicolau, Petr Widimský, Elliott M. Antman, Stephen D. Wiviott

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  7. 7
    Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

    Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PL... מאת Pontus Andell, Stefan James, Christopher P. Cannon, Derek D. Cyr, Anders Himmelmänn, Steen Husted, Matyàs Keltai, Sasha Koul, Anwar Santoso, Philippe Gabríel Steg, Robert F. Storey, Lars Wallentin, David Erlinge

    יצא לאור 2015
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  8. 8
    Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y <sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

    Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y <sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndrom... מאת Francesco Franchi, Stefan James, Tatevik Ghukasyan Lakic, Andrzej Budaj, Jan H. Cornel, Hugo A. Katus, Matyàs Keltai, Frederic Kontny, Basil S. Lewis, Robert F. Storey, Anders Himmelmänn, Lars Wallentin, Dominick J. Angiolillo

    יצא לאור 2019
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  9. 9
    Effects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 Trial

    Effects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 Trial מאת Gilles R. Dagenais, Hye Jung Jung, Eva Lonn, Peter Bogaty, Mahshid Dehghan, Claes Held, Álvaro Avezum, Petr Janský, Matyàs Keltai, Lawrence A. Leiter, Patricio López‐Jaramillo, William D. Toff, Jackie Bosch, Salim Yusuf

    יצא לאור 2018
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  10. 10
    Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial

    Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Pr... מאת Philip Joseph, Eva Lonn, Jackie Bosch, Patricio López, Jun Zhu, Matyàs Keltai, Anthony Dans, Christopher M. Reid, Kamlesh Khunti, William D. Toff, Leopoldo Soares Piegas, Jae‐Hyung Kim, Balakumar Swaminathan, Michael Böhm, Salim Yusuf

    יצא לאור 2017
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  11. 11
    Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose

    Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose מאת Gilles R. Dagenais, Hertzel C. Gerstein, R Holman, Andrzej Budaj, A Escalante, Thomas Hedner, Matyàs Keltai, Eva Lonn, Samy I. McFarlane, M. McQueen, Koon Teo, Patrick Sheridan, Jackie Bosch, Janice Pogue, Salim Yusuf

    יצא לאור 2008
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  12. 12
    Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function

    Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function מאת Stefan James, Andrzej Budaj, Philip E. Aylward, Kristen Buck, Christopher P. Cannon, Jan H. Cornel, Robert A. Harrington, Jay Horrow, Hugo Katus, Matyàs Keltai, Basil S. Lewis, Keyur Parikh, Robert F. Storey, Karolina Szummer, Daniel Wojdyla, Lars Wallentin

    יצא לאור 2010
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  13. 13
    Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack

    Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack מאת Stefan James, Robert F. Storey, Nardev S. Khurmi, Steen Husted, Matyàs Keltai, Kenneth W. Mahaffey, Juan Maya, João Morais, Renato D. Lópes, José Carlos Nicolau, Prem Pais, Dimitar Raev, José López‐Sendón, Susanna R. Stevens, Richard C. Becker

    יצא לאור 2012
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  14. 14
    Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

    Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic... מאת B. Daan Westenbrink, Marco Alings, Christopher B. Granger, John H. Alexander, Renato D. Lópes, Elaine M. Hylek, Laine Thomas, Daniel Wojdyla, Michael Hanna, Matyàs Keltai, Philippe Gabríel Steg, Raffaele De Caterina, Lars Wallentin, Wiek H. van Gilst

    יצא לאור 2016
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  15. 15
    Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial

    Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial מאת Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lópes, Daniel Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. Cecilia Bahit, Matyàs Keltai, José López‐Sendón, Prem Pais, Witold Rużyłło, Lars Wallentin, Christopher B. Granger, John H. Alexander

    יצא לאור 2015
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  16. 16
    Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation

    Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation מאת Greg Flaker, Renato D. Lópes, Elaine M. Hylek, Daniel Wojdyla, Laine Thomas, Sana M. Al‐Khatib, Renee M. Sullivan, Stefan H. Hohnloser, David García, Michael Hanna, John Amerena, Veli-Pekka Harjola, Paul Dorian, Álvaro Avezum, Matyàs Keltai, Lars Wallentin, Christopher B. Granger

    יצא לאור 2014
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  17. 17
    The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia

    The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia מאת Louise Bordeleau, Natalia Yakubovich, Gilles R. Dagenais, Julio Rosenstock, Jeffrey L. Probstfield, Pan Chang Yu, Lars Rydén, Valdis Pīrāgs, Giatgen A. Spinas, Kåre I. Birkeland, Robert E. Ratner, José Antônio Marin‐Neto, Matyàs Keltai, Matthew C. Riddle, Jackie Bosch, Salim Yusuf, Hertzel C. Gerstein

    יצא לאור 2014
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  18. 18
    Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy

    Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy מאת Pedro Sílvio Farsky, Jennifer A. White, Hussein R. Al‐Khalidi, Carla A. Sueta, Jean L. Rouleau, Julio A. Panza, Eric J. Velazquez, Christopher M. O’Connor, Rafał Dąbrowski, Ljubomir T. Djokovic, Mark H. Drazner, Haissam Haddad, Imtiaz S. Ali, Matyàs Keltai, Ajay Naik, George Sopko, Krzysztof S. Gołba, Bert Andersson, Peter E. Carson, Tomasz Kukulski

    יצא לאור 2021
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  19. 19
    Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction

    Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction מאת David Wood, John A. Cairns, Jia Wang, Roxana Mehran, Robert F. Storey, Helen Nguyen, Brandi Meeks, Vijay Kunadian, Jean‐François Tanguay, Hahn-Ho Kim, Asim N. Cheema, Payam Dehghani, Madhu K. Natarajan, Sanjit S. Jolly, John Amerena, Matyàs Keltai, Stefan James, Ota Hlinomaz, Kari Niemelä, Khalid F. AlHabib, Basil S. Lewis, Michel Nguyen, Jaydeep Sarma, Vladimír Džavík, Anthony Della Siega, Shamir R. Mehta

    יצא לאור 2019
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  20. 20
    Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity

    Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity מאת Harmony R. Reynolds, Leslee J. Shaw, James K. Min, Courtney Page, Daniel S. Berman, Bernard Chaitman, Michael H. Picard, Raymond Y. Kwong, Sean M. O’Brien, Zhen Huang, Daniel B. Mark, Ranjit Kumar Nath, Sudhanshu Kumar Dwivedi, Paola Smanio, Peter H. Stone, Claes Held, Matyàs Keltai, Sripal Bangalore, Jonathan Newman, John A. Spertus, Gregg W. Stone, David J. Maron, Judith S. Hochman

    יצא לאור 2021
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: